Carl Jenson, MD
Radiation Oncology · Coos Bay, ORNPI 1659317097
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 8.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $581 and has fallen 74.3% since, to $149 in 2025.
Across 59 payments — averaging $32.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$159
- Novartis$144
- Amgen$141
- Takeda Pharmaceuticals U.S.A., Inc.$131
- Teleflex LLC$125
- Mirati Therapeutics, Inc.$125
- plus $1K from 28 others
What the payments were for
- Food & beverage$1,82695%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $159 |
| Novartis | 7 | $144 |
| Amgen | 3 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $131 |
| Teleflex LLC | 1 | $125 |
| Mirati Therapeutics, Inc. | 1 | $125 |
| Gilead | 1 | $120 |
| E.r. Squibb & Sons, L.L.C. | 3 | $102 |
| Sumitomo Pharma America, Inc. | 3 | $79 |
| Daiichi Sankyo Inc. | 2 | $58 |
| Novocure Inc. | 2 | $54 |
| Bayer | 3 | $52 |
| AstraZeneca | 2 | $50 |
| Merck | 2 | $49 |
| AbbVie | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| GSK | 2 | $41 |
| Incyte Corporation | 2 | $38 |
| Seagen Inc. | 2 | $36 |
| Stemline Therapeutics Inc. | 1 | $34 |
| Sobi, Inc | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| ADC Therapeutics America, Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $27 |
| Bristol Myers Squibb | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $17 |
| Sanofi | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Pharmaessentia USA Corporation | 1 | $15 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,926 in reported general payments places this provider in the 85th percentile of 93 radiation oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 34 | $280 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Coos Bay
- Brian FullerCoos Bay$791
- Timur MitinHillsboro$58K
- Marka CrittendenPortland$20K
- William ArscottTigard$16K
- Steven SeungPortland$11K
- Joshua WalkerPortland$9K
- Andrew KeePortland$7K
- Haidy LeeEugene$5K
- Brandon DyerPortland$4K
- Nima NabavizadehPortland$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.